TSPAN32 and chronic myelogenous leukemia, BCR-ABL1 positive: When comparing the effects of TSPAN32 on CML (Fig. 3c) and B-ALL (Fig. 6d), TSPAN32 may have a stronger suppressive effect on B-ALL than CML.